ClinicalTrials.Veeva

Menu

Mirror Medacta Shoulder System Pivotal Trial

M

Medacta

Status

Enrolling

Conditions

Arthritis Shoulder
Post-traumatic Arthrosis of Other Joints, Upper Arm

Treatments

Device: Medacta Shoulder System
Device: Mirror Medacta Shoulder System

Study type

Interventional

Funder types

Industry

Identifiers

NCT05062252
P06.003.01

Details and patient eligibility

About

The purpose of this study is to demonstrate safety and efficacy of the Mirror Medacta Shoulder System in total shoulder arthroplasty.

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age ≥ 18 yr
  • Clinical indication for anatomic primary total shoulder replacement due to osteoarthritis and/or posttraumatic arthritis
  • Willingness and ability to comply with study protocol

Exclusion criteria

  • Medical condition or balance impairment that could lead to falls
  • Prior rotator cuff surgery
  • Cuff tear arthropathy/insufficient rotator cuff
  • Insufficient bone quality which may affect the stability of the implant
  • Neuromuscular compromise of shoulder or other disabilities affecting the maximum functional outcomes
  • Weight bearing shoulder due to wheel chair, crutches, rollator at the time of operation
  • Active metastatic or neoplastic disease at the shoulder joint
  • Chemotherapy treatment/radiotherapy within 6 mo before surgery
  • >5 mg/day of corticosteroids, excluding inhalers, within 3 years before surgery
  • Pregnancy or plan to become pregnant during study period
  • Inability to understand study or a history of noncompliance with medical advice
  • Alcohol or drug abuse
  • Current enrollment in any clinical research study that might interfere with this study
  • Metal allergies or sensitivity.
  • Previous or current infection at or near the site of implantation.
  • Current distant or systemic infection
  • Patient, whose infomed consent form should be taken in an emergency situation
  • ONLY for women of childbearing age: a positive pregnancy test (urine / blood)

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

100 participants in 2 patient groups

Mirror group
Experimental group
Description:
Mirror Medacta Shoulder System
Treatment:
Device: Mirror Medacta Shoulder System
Historical Control group
Active Comparator group
Description:
Total shoulder arthroplasty system
Treatment:
Device: Medacta Shoulder System

Trial contacts and locations

2

Loading...

Central trial contact

Marco Viganò, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems